This article aligns with the SDG goal 3 of Good health and wellbeing and SDG 10 Reduced inequalities by showing that hepatitis C mortality trends in Mexico have started to decrease, but that much remains to be done in terms of prevention, diagnosis and timely access to treatment in this country.
Elsevier,
Clinical Neuroepidemiology of Acute and Chronic Disorders, First Edition, 2023, pp 199-211
This chapter advances the UN SDG goals 3 and 17 by reviewing the basics understandings of delirium and dementia.
This Article supports Sustainable Development Goal 3 by showing a positive association between hearing loss without hearing aid use and dementia in adults aged 40-69 years in the UK. The authors analysed all-cause dementia, as well as specific types including Alzheimer's disease. Hearing loss was associated with increased risk of dementia, and using hearing aids was associated with a similar risk of dementia to no hearing loss, suggesting that hearing aid use in people with hearing loss could reduce dementia risk.
Nitric Oxide can act as both protecting and aggravating factor in Alzheimer's Disease. Nitric oxide can be considered as a neurotoxic factor in Alzheimer's Disease. Nitric Oxide induces neuro plasticity, neuroprotection, neurogenesis, long-term potentiation, and myelination. Drugs based on Nitric Oxide have shown promising results in Alzheimer's Disease. Nitric Oxide can via sundry ways ameliorate memory formation.
This study assessed the central auditory processing (CAP) function and its electroencephalogram (EEG) in patients with mild cognitive impairment (MCI) and the early stage of Alzheimer's disease (AD) so as to provide a basis for early recognition and intervention of AD.
An insightful paper on the effects that Nordic Walking can have on the cognitive function of patients with mild Alzheimer’s disease.
This content supports the SDG Goal 3: Good health and well-being by examining current hepatitis B vaccines as a solution toward the elimiation of HBV as a public health treat.
This chapter aligns with Goal 14: Life Below Water and Goal 3: Good Health and Wellbeing by highlighting some of the many beneficial industrial and pharmaceutical applications of marine microalgae.
